Abcam gains after securing all approvals for Danaher sale, set to close Dec. 6
Abcam gains after securing all approvals for Danaher sale, set to close Dec. 6
Abcam ticks higher amid report of China approval for sale to Danaher
Shareholders of Abcam approve proposed acquisition by Danaher
Abcam holder Starboard Value said to sell stake - report
Abcam holders should vote for sale to Danaher, proxy adviser ISS says
Abcam received multiple bids in sales process, contacted over 30 parties
5.12BUSD
Jenis
Common Stock
Menukarkan
PINK
Kode mata uang
USD
Nama Mata Uang
US Dollar
Nama negara
USA
ISO Negara
US
ADALAH
-
CUSIP
-
Sektor
Healthcare
Industri
Biotechnology
Akhir Tahun Anggaran
June
tanggal IPO
-
Diperbarui Pada
-
Rasio PE
2,225.00
Rasio PEG
-
Nilai buku
3.14
Pembagian Dividen
-
Hasil Dividen
-
Bagi Hasil
0.01
Target Harga Wall Street
-
Estimasi EPS Tahun Ini
0
Estimasi EPS Tahun Depan
0
Perkiraan EPS Kuartal Saat Ini
0
Estimasi EPS Kuartal Berikutnya
0
Kuartal Terbaru
-
Pendapatan TTM
379,700,000
TTM Laba Kotor
270,500,000
EBITDA
106,000,000
Margin Keuntungan
0.66%
Pengembalian Aset TTM
4.36%
Pengembalian Ekuitas TTM
0.35%
Pendapatan Per Saham TTM
1.658
Pertumbuhan Pendapatan Kuartalan YOY
9.70%
Eps TTM yang diencerkan
0.01
Pertumbuhan Pendapatan Kuartalan YOY
188.00%
tertinggal PE
2225.00
Maju PE
32
Harga Jual TTM
13.4866
Buku Harga MRQ
5.6658
Pendapatan Nilai Perusahaan
11
EBITDA Nilai Perusahaan
67
169.54
3.19%82.79
1.96%695.70
0.72%414.00
0.56%86.83
0.51%240.51
0.02%655.00
0.00%194.85
0.00%34.06
-1.15%97.63
-0.27%